TARO-FUSIDIC ACID DIN 02528096
Status: Marketed
Holder: TARO PHARMACEUTICALS INC
Molecule: FUSIDIC ACID (FUSIDIC ACID HEMIHYDRATE)
Available to quote
Health Canada record
| Active ingredient(s) | FUSIDIC ACID (FUSIDIC ACID HEMIHYDRATE) 2 % |
|---|---|
| Dosage form | Cream |
| Route | Topical |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | D06AX01 FUSIDIC ACID |
| Original market date | 22-May-2024 |
| Current status date | 22-May-2024 |
| Source | Health Canada DPD |
Establishment licence of the holder
Taro Pharmaceuticals Inc — licence 100232, not currently licensed, last inspection rating C (2025-03-24).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 28405 | 2022-06-17 | Abbreviated New Drug Submission (ANDS) |